Eighty-three participants, aged between 33 and 50 years, completed the study
No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
A licensed provider reviews your intake and prescribes if appropriate
Your Partner in Long-Term Wellness Whether you're transitioning off prescription GLP-1 medications, or simply looking for a natural appetite modulator, this formula is designed to help sustain balanced eating patterns and metabolic resilience
Long-term effects require laboratory measurement of telomere length or biomarkers of cellular aging
If MHRA approval arrives in late 2027 to mid-2028, private availability could follow within weeks, as it did with Mounjaro and Wegovy